Position in UTHR
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$126,592,619
+$53,394,575 QoQ
Shares Held
233,639
+89.3% QoQ
Ownership
0.545%
of shares outstanding
% of Portfolio
0.14%
of 13F equity value
Holder Rank
#40
of 870 holders
Holding Since
Jun 2020
22 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in UTHR Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Qube Research & Technologies Ltd holds $592,833,307 across 20 Drug Manufacturers - Specialty & Generic names. UTHR ranks #2 (21.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
2,279,333 | $163,792,869 | |
| 2 | UTHR |
UNITED THERAPEUTICS Corp
This page
|
233,639 | $126,592,619 | |
| 3 | VTRS |
Viatris Inc
|
6,180,223 | $98,141,941 | |
| 4 | SUPN |
Supernus Pharmaceuticals, Inc.
|
922,166 | $42,889,940 | |
| 5 | TAK |
Takeda Pharmaceutical Co Ltd
|
2,207,432 | $35,385,134 | |
| 6 | XERS |
Xeris Biopharma Holdings, Inc.
|
2,893,749 | $22,918,492 | |
| 7 | KNSA |
Kiniksa Pharmaceuticals International, plc
|
304,080 | $19,445,916 | |
| 8 | ANIP |
Ani Pharmaceuticals Inc
|
192,945 | $15,971,987 |
All Filings in UTHR
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $126,592,619 | 233,639 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $73,198,044 | 123,441 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $47,898,624 | 98,304 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $12,408,196 | 29,599 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $43,417,148 | 151,095 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $56,287,019 | 182,590 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $38,933,424 | 110,343 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $19,283,888 | 53,813 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $10,096,442 | 31,695 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $42,419,405 | 184,657 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $45,131,103 | 205,244 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $18,965,174 | 83,965 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $17,598,190 | 79,720 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $39,454,361 | 176,167 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $40,310,814 | 144,956 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $14,030,553 | 67,010 | Shares | Sole | 2022-11-14 | |
| 2022-03-31 | $2,791,081 | 15,557 | Shares | Sole | 2022-05-09 | |
| 2021-09-30 | $12,203,137 | 66,113 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $2,549,236 | 14,209 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $1,288,648 | 7,704 | Shares | Sole | 2021-05-14 | |
| 2020-09-30 | $4,874,159 | 48,259 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $5,234,944 | 43,264 | Shares | Sole | 2020-08-14 | |
| No filing history on record for this holder in this stock. | ||||||